Ezabenlimab (Bi 754091), An Anti-Pd-1 Antibody, In Combination With Bi 836880, A Vegf/Ang2-Blocking Nanobody, In Patients (Pts) With Previously Treated Advanced Solid TumoursM. Hussein, I. Percent, E. Arrowsmith,H-T. Arkenau,Q. Chu, A. R. Hansen, D. Erzen, S. Qiu, A. Lucarelli,S. UlahannanANNALS OF ONCOLOGY（2021）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
